Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease

Overview of attention for article published in The Application of Clinical Genetics, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 15 Mendeley

Summary X

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 23,719 followers.

RT @apef_figado: Great review about non-HFE HH 👇 📌 Consider testing in patients with documented iron overload after other causes if…

30 Aug 2021

Reply Repost Favourite

Great review about non-HFE HH 👇 📌 Consider testing in patients with documented iron overload after other causes if have been exclude, especially among patients with a family history of iron overload. https://t.co/TfSWgaMTKa

30 Aug 2021

Reply Repost Favourite

RT @KowdleyMd: Pleased to share our latest review article: Appropriate Clinical Genetic Testing of Hemochromatosis Type 2-4, Including Ferr…

28 Aug 2021

Reply Repost Favourite

RT @KowdleyMd: Pleased to share our latest review article: Appropriate Clinical Genetic Testing of Hemochromatosis Type 2-4, Including Ferr…

28 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.